Form 4: MannKind Director Steven Binder Sells Shares Following Restricted Stock Vesting

MannKind Corp. Director Steven B. Binder reported the sale of 75,367 shares of common stock and the disposition of 19,383 shares for tax liability, reducing his direct beneficial ownership to 830,508 shares.

Summary

• Steven B. Binder, a Director of MannKind Corp. (MNKD), reported transactions involving the company's common stock.
• On July 15, 2025, 19,383 shares of common stock were disposed of at a price of $3.85 per share. This transaction was for the payment of exercise price or tax liability incident to the vesting of previously reported restricted stock units.
• On July 16, 2025, 75,367 shares of common stock were sold at a weighted average price of $3.94 per share. The sales occurred within a price range of $3.91 to $3.97.
• The sale on July 16, 2025, was executed pursuant to a Rule 10b5-1 Plan established on August 16, 2024.
• Following these transactions, Steven B. Binder directly beneficially owns 830,508 shares of MannKind Corp. common stock.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, even though it's under a 10b5-1 plan. While routine, it represents a reduction in insider holdings. The disposition for tax liability is neutral.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 plan, indicating a pre-planned transaction rather than a reaction to immediate market conditions.

Negatives

• A director sold a significant number of shares (75,367 shares) in the open market.
• An additional 19,383 shares were disposed of to cover tax liabilities related to vested restricted stock units, which reduces the director's direct holdings.

Risks

• Insider selling, even if pre-planned, can sometimes be perceived negatively by investors, potentially signaling a lack of confidence or a desire to diversify holdings.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports insider trading activity.

Management Comments

• The weighted average sales price of the reported transaction was $3.94 based on a range of prices between $3.91 and $3.97.
• Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the Issuer, or any security holder of the Issuer.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. It is a routine disclosure of a director's stock activity.

Comparison to Industry Standards

• This document is a standard SEC Form 4 filing, which reports changes in beneficial ownership by insiders. The transactions reported are specific to an individual director and do not offer a basis for comparison to industry-wide financial performance or operational benchmarks.
• The sale under a Rule 10b5-1 plan is a common practice for insiders to manage their stock holdings in compliance with insider trading regulations, similar to practices seen at companies like Pfizer (PFE) or Eli Lilly (LLY) where executives often use such plans for pre-scheduled stock sales.

Stakeholder Impact

• Shareholders: The sale by a director could be perceived as a slight negative signal, though the Rule 10b5-1 plan mitigates immediate concerns about confidence. It reduces the director's direct stake in the company.

Next Steps

• The document does not specify any future actions or milestones for the company. It is a historical report of insider transactions.

Key Dates

Recommendation

Keywords

MannKind Corp, MNKD, Steven B. Binder, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Rule 10b5-1 Plan, Director, SEC Filing